J Grahampole

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A central facility for ex vivo removal of neuroblastoma cells from bone marrow, to be used for autologous reinfusion after myeloablative treatment, was established and a study was designed to compare the survival time and the rate of bone marrow engraftment between local marrows obtained and processed at the University of Florida (UF) and marrow transported(More)
We have previously reported on a study of a small number of patients with advanced neuroblastoma (NBL) receiving myeloablative treatment and autologous marrow rescue in which occult NBL cells were found in the marrow of almost every transplanted patient. In addition, we have shown that the incidence of later relapse correlated better with the N-myc protein(More)
  • 1